Lymphomas, which express a dominant-negative FoxO mutant (dnFoxO), exhibit low ARF mRNA levels, regardless of the p53 status, implying that FoxO is involved in ARF transcriptional regulation. This evidence concerns the gene CDKN2A and lymphoma.